News / Presse
HAPILA and Transo-Pharm expand cooperation
HAPILA GmbH and Transo-Pharm Handels-GmbH are determined to deepen their relationship and have therefore jointly decided to expand the production capacities at the HAPILA site in Gera, mainly to meet the increasing demand for the active ingredient Estriol Micronized.
The planning for the construction and installation work started in 2020.
The new facility is expected to be completed in 2022.